<DOC>
	<DOCNO>NCT01175694</DOCNO>
	<brief_summary>Accelerated partial breast irradiation ( APBI ) lead equivalent local control rate lower toxicity external beam irradiation ( EBI ) breast conserve surgery ( BCS ) highly select subgroup patient low risk invasive carcinoma low risk duct carcinoma in-situ ( DCIS ) . The goal trial assess role modify dose pulsed-dose-rate ( PDR ) high-dose-rate ( HDR ) brachytherapy alone Accelerated Partial Breast Irradiation ( APBI ) define low-risk group invasive breast cancer ductal carcinoma situ concern local failure ( ipsilateral local recurrence ) , particular regard local recurrence , toxicity cosmetic result . It phase II study . According study protocol altogether 200 female patient treat .</brief_summary>
	<brief_title>Dose Optimization Pulsed-dose-rate ( PDR ) /High-dose-rate ( HDR ) Brachytherapy Alone Early Breast Cancer</brief_title>
	<detailed_description>Focus trial ass role modify dose PDR- HDR-brachytherapy Accelerated Partial Breast Irradiation ( APBI ) alone define low-risk group invasive breast cancer ductal carcinoma situ concern local failure ( ipsilateral local recurrence , particular regard local recurrence , toxicity cosmetic result .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>Inclusion criterion Stage 0 , I II breast cancer . Invasive ductal , papillary , mucinous , tubular , medullary lobular carcinoma . Ductal carcinoma situ ( DCIS ) alone . No lymph invasion ( L0 ) hemangiosis ( V0 ) . Lesions &lt; 3 cm diameter , histopathologically assure . pN0 ( minimum 6 node specimen , negative sentinel node acceptable ) . M0 . Clear resection margin least 2 mm direction ; lobular histology DCIS histology resection margin must clear least 5 mm . For DCIS : lesion must classify low intermediate risk group Unifocal unicentric DCIS breast cancer . Age &gt; 50 year . Time interval final definitive breast surgical procedure start external beam therapy brachytherapy le 12 week ( 84 day ) . If patient receive chemotherapy radiotherapy start systemic treatment ( within 12 week ) . The radiation therapy also give interval chemotherapy course . It also possible start radiation therapy chemotherapy complete accord local protocol soon possible within 4 week chemotherapy . Signed studyspecific consent form Stage III IV breast cancer . Surgical margin microscopically assess . Extensive intraductal component ( EIC ) . Paget 's disease pathological skin involvement . Synchronous previous breast cancer . Prior malignancy ( &lt; 5 year prior enrollment study ) except nonmelanoma skin cancer cervical carcinoma International Federation Gynecology Obstetrics ( FIGO ) 0 I patient continuously diseasefree . Pregnant lactating woman . Collagen vascular disease . The presence congenital disease increase radiation sensitivity , example Ataxia telangiectatic similar . Psychiatric disorder . Patient breast deem technically unsatisfactory brachytherapy .</criteria>
	<gender>Female</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2010</verification_date>
	<keyword>Brachytherapy</keyword>
	<keyword>APBI</keyword>
	<keyword>dose modification</keyword>
	<keyword>local recurrence</keyword>
	<keyword>side effect</keyword>
	<keyword>cosmetic result</keyword>
</DOC>